European Quality of Care Pathways Study on Chronic Obstructive Pulmonary Disease (COPD)
Launched by EUROPEAN PATHWAY ASSOCIATION · Aug 19, 2009
Trial Information
Current as of May 27, 2025
Completed
Keywords
ClinConnect Summary
Healthcare is changing towards more patient focused care. The organization of the care process related to quality, efficiency and accessibility is one of the main areas of interest within the next years for clinicians, healthcare managers and policy makers. A main method to (re)organize a care process is the development and implementation of a care pathway. Care pathways, also known as clinical pathways or critical pathways, are used worldwide for a variety of patient groups. The European Pathway Association (E-P-A) defines a care pathway as: "A complex intervention for the mutual decision ...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- Inclusion criteria on cluster level are:
- • 1. Written agreement to participate in the study;
- • 2. Agreement that a care pathway for COPD will not be developed and used within the time frame of the study when randomized in the control group.
- Inclusion criteria on patient level are:
- • 1. Written informed consent;
- • 2. All consecutive admissions with COPD exacerbation;
- • 3. Hospitalization for at least 48 hours;
- • 4. Moderate, severe or very severe COPD;
- • 5. Each patient will be included only once in the study at initial hospitalization, even if the patient had been hospitalized more than once.
- Exclusion Criteria:
- Exclusion criteria on patient level:
- • 1. Admission required to intensive care unit;
- • 2. Need for Invasive Positive Pressure Ventilation (IPVV).
- Inclusion criteria on multidisciplinary team level:
- • 1. Team members are involved in direct patient care responsibilities for COPD;
- • 2. Minimum representation of the core disciplines according to COPD literature;
About European Pathway Association
The European Pathway Association (EPA) is a leading organization dedicated to advancing the field of clinical pathways in healthcare. Committed to enhancing patient care through evidence-based practices, the EPA fosters collaboration among healthcare professionals, researchers, and policymakers across Europe. By promoting the development and implementation of clinical pathways, the association aims to improve health outcomes, optimize resource utilization, and streamline healthcare processes. Through innovative research and educational initiatives, the EPA plays a pivotal role in shaping the future of healthcare delivery, ensuring that best practices are translated into effective clinical solutions.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Trial Officials
Kris Vanhaecht, PhD
Study Director
KU Leuven
Walter Sermeus, PhD
Principal Investigator
KU Leuven
Massimiliano Panella, PhD
Principal Investigator
Amedeo Avogadro University of Eastern Piemont
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials